173 related articles for article (PubMed ID: 35535154)
1. Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of
Wang S; Liu Y; Wang Q; Xu X; Huang T; Dong P; Wang L; Cao B; Jiao Q; Sun X; Li J; Wang T
Evid Based Complement Alternat Med; 2022; 2022():9862733. PubMed ID: 35535154
[TBL] [Abstract][Full Text] [Related]
2. Exploring the pharmacological mechanisms of
Lu M; Ou J; Deng X; Chen Y; Gao Q
Heliyon; 2023 Jun; 9(6):e17550. PubMed ID: 37416640
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of
Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
[No Abstract] [Full Text] [Related]
4. Integrated study reveals mechanism of Tripterygium Wilfordii against cholangiocarcinoma based on bioinformatics approaches and molecular dynamics simulation.
Zhao Y; Guo J
Comput Biol Chem; 2024 Apr; 109():108030. PubMed ID: 38387122
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the Mechanism of Tripterygium Wilfordii in the Treatment of Myocardial Fibrosis Based on Network Pharmacology and Molecular Docking.
Ming Y; Jiachen L; Tao G; Zhihui W
Curr Comput Aided Drug Des; 2023; 19(1):68-79. PubMed ID: 36306461
[TBL] [Abstract][Full Text] [Related]
6. Study of the Active Components and Molecular Mechanism of
Wang L; Wang Z; Yang Z; Yang K; Yang H
Front Mol Biosci; 2021; 8():664416. PubMed ID: 34164430
[TBL] [Abstract][Full Text] [Related]
7. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
[TBL] [Abstract][Full Text] [Related]
8. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Pharmacological Mechanisms of
Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N
Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046
[TBL] [Abstract][Full Text] [Related]
10. Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model.
Han X; Li C; Yang P; Jiang T
Ann Transl Med; 2022 Apr; 10(8):453. PubMed ID: 35571420
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of
Shi H; Hou Y; Su X; Qiao J; Wang Q; Guo X; Gao Z; Wang L
Ren Fail; 2022 Dec; 44(1):116-125. PubMed ID: 35172688
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
Que DH; Chen WH; Jiang FP; Pan F; Yang K
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
[TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology and Molecular Docking Analysis Exploring the Mechanism of
Huang W; Huang X; Yang L; Han W; Zhu Z; Wang Y; Chen R
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629739
[No Abstract] [Full Text] [Related]
14. Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang.
Jin J; Chen B; Zhan X; Zhou Z; Liu H; Dong Y
PLoS One; 2021; 16(6):e0252508. PubMed ID: 34125845
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways.
Zhu W; Wang Y; Liu C; Wu Y; Li Y; Wang Y
Front Pharmacol; 2022; 13():990760. PubMed ID: 36419618
[No Abstract] [Full Text] [Related]
16. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
17. A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn's disease.
Zhang J; Huang Q; Zhao R; Ma Z
BMC Complement Med Ther; 2020 Mar; 20(1):95. PubMed ID: 32293395
[TBL] [Abstract][Full Text] [Related]
18. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology, molecular docking and bioinformatics reveal the mechanism of Tripterygii Wilfordii against Osteosarcoma.
Zhang Y; Wei J; Kong L; Song M; Zhang Y; Xiao X; Cao H; Jin Y
Medicine (Baltimore); 2022 Dec; 101(52):e32389. PubMed ID: 36595977
[TBL] [Abstract][Full Text] [Related]
20. Integrating network pharmacology and experimental verification to explore the mechanism of Tripterygium wilfordii in ankylosing spondylitis.
Chen Y; Liu Z; Yu Q; Qu X; Liu H
Medicine (Baltimore); 2023 Dec; 102(50):e36580. PubMed ID: 38115356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
